Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Eli Lilly and Company
Theravectys S.A.
Perspective Therapeutics
Second Life Therapeutics
National Institutes of Health Clinical Center (CC)
BicycleTx Limited
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
UNICANCER
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
Compugen Ltd
SCG Cell Therapy Pte. Ltd.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
GeneMedicine Co., Ltd.
Dana-Farber Cancer Institute
CytomX Therapeutics
Klus Pharma Inc.
Kineta Inc.
Advaxis, Inc.
Incyte Corporation
Petra Pharma
Memorial Sloan Kettering Cancer Center
Centocor, Inc.
Memorial Sloan Kettering Cancer Center
Duke University